Journal
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY
Volume 32, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.pdpdt.2020.102086
Keywords
Antibiotic resistance; beta-lactams; Enzymatic inactivation; Photoantimicrobial; Photoinactivation; Visible light; Antimicrobial Photodynamic Therapy
Categories
Funding
- Sao Paulo Research Foundation (FAPESP) [2016/25095-2, 2017/22406-0, 2019/10851-4]
- Brazilian National Council for Scientific and Technological Development (CNPq) [141901/2016-0]
- Photonics Institute (INFO) [465763/2014-6]
- CNPq [312249/2017-9]
Ask authors/readers for more resources
Introduction: The production of beta-lactamases by Gram-negative bacteria is among the most important factors of resistance to antibiotics, which has contributed to therapeutic failures that currently threaten human and veterinary medicine worldwide. Antimicrobial photodynamic therapy and antimicrobial blue light have a broadspectrum antibacterial activity against multidrug-resistant and hypervirulent pathogens. Objective: To investigate the ability of antimicrobial blue light to inhibit the hydrolytic activity of clinically relevant beta-lactamase enzymes (i.e., KPC, IMP, OXA, CTX-M, and SHV), with further comparison of the inhibitory effects of antimicrobial blue light with methylene blue-mediated antimicrobial photodynamic therapy. Methods: Blue LED light (A = 410 +/- 10 nm) alone or red LED light (A = 660 +/- 10 nm) in combination with methylene blue were used to inactivate, in vitro, suspensions of Klebsiella pneumoniae strains producing clinically important beta-lactamase enzymes assigned to the A, B and D Ambler molecular classes. Furthermore, beta-lactamase activity inhibition mediated by antimicrobial blue light and methylene blue-mediated antimicrobial photodynamic therapy was measured by using the chromogenic beta-lactam substrate nitrocefin. Results: beta-lactamase activities were effectively inactivated by both visible light-based approaches. In this regard, antimicrobial blue light and methylene blue-antimicrobial photodynamic therapy led to a significant reduction in the hydrolysis of nitrocefin (81-98 %). Conclusion: Sublethal doses of antimicrobial blue light and methylene blue-mediated antimicrobial photodynamic therapy are equally effective to inhibit clinically significant beta-lactamases, including extended-spectrum beta-lactamases and carbapenemases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available